Newark, NJ6 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Newark, NJ

Find 6 actively recruiting myalgic encephalomyelitis clinical trials in Newark, NJ. Connect with local research sites and explore new treatment options.

6
Active Trials
6
Sponsors
1,692
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Newark

About Myalgic Encephalomyelitis Clinical Trials in Newark

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 6 myalgic encephalomyelitis clinical trials recruiting participants in Newark, NJ. These studies are seeking a combined 1,692 participants. Research is being sponsored by Eikon Therapeutics, University of Delaware, Regeneron Pharmaceuticals and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Newark — FAQ

Are there myalgic encephalomyelitis clinical trials in Newark?

Yes, there are 6 myalgic encephalomyelitis clinical trials currently recruiting in Newark, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Newark?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Newark research site will contact you about next steps.

Are clinical trials in Newark free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Newark studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 6 active trials in Newark are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated October 21, 2026 from ClinicalTrials.gov